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Background: Chronic diseases are an increasing threat to people’s health and to the sustainability of health
organisations. Despite the need for routine monitoring systems to assess the impact of chronicity in the population
and its evolution over time, currently no single source of information has been identified as suitable for this
purpose. Our objective was to describe the prevalence of various chronic conditions estimated using routine data
recorded by health professionals: diagnoses on hospital discharge abstracts, and primary care prescriptions and
diagnoses.
Methods: The ICD-9-CM codes for diagnoses and Anatomical Therapeutic Chemical (ATC) codes for prescriptions
were collected for all patients in the Basque Country over 14 years of age (n=1,964,337) for a 12-month period. We
employed a range of different inputs: hospital diagnoses, primary care diagnoses, primary care prescriptions and
combinations thereof. Data were collapsed into the morbidity groups specified by the Johns Hopkins Adjusted
Clinical Groups (ACGs) Case-Mix System. We estimated the prevalence of 12 chronic conditions, comparing the
results obtained using the different data sources with each other and also with those of the Basque Health
Interview Survey (ESCAV). Using the different combinations of inputs, Standardized Morbidity Ratios (SMRs) for the
considered diseases were calculated for the list of patients of each general practitioner. The variances of the SMRs
were used as a measure of the dispersion of the data and were compared using the Brown-Forsythe test.
Results: The prevalences calculated using prescription data were higher than those obtained from diagnoses and
those from the ESCAV, with two exceptions: malignant neoplasm and migraine. The variances of the SMRs obtained
from the combination of all the data sources (hospital diagnoses, and primary care prescriptions and diagnoses)
were significantly lower than those using only diagnoses.
Conclusions: The estimated prevalence of chronic diseases varies considerably depending of the source(s) of
information used. Given that administrative databases compile data registered for other purposes, the estimations
obtained must be considered with caution. In a context of increasingly widespread computerisation of patient
medical records, the complementary use of a range of sources may be a feasible option for the routine monitoring
of the prevalence of chronic diseases.
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The chronification of certain diseases and growing life ex-
pectancy of populations of most countries are leading to
an increase in the number of people living with one or
more chronic diseases [1,2]. Chronicity, as a wide frame-
work for understanding the phenomenon of chronic condi-
tions in relation to patients, their families, communities
and health systems, forces us to reconsider current models
of service provision and the role of patients with regard to
their condition [3,4]. In relation to this, a strategy for tack-
ling the challenges of chronicity was published in 2010 in
the Basque Country [5]. It proposes medium-term changes
to organise the provision of health services in an innovative
way and requires the use of new information systems as a
management tool when planning interventions to provide
healthcare for these patients.
It is widely accepted that there is no single source of in-
formation from which we can obtain all the data necessary
for routine monitoring of chronic diseases [6]. For this rea-
son, a range of different methods are employed: demo-
graphic statistics, population surveys, specific disease
registers, hospital discharge data sets and other administra-
tive databases, as well as algorithms designed to obtain in-
formation from electronic health records (EHR) and other
complex systems [7-11]. Each of these approaches has its
pros and cons. In the case of administrative healthcare
databases, they present as a flaw that only offer informa-
tion about attended morbidity; their main advantages are
that, as they contain data already recorded for other pur-
poses, they tend to be easier to handle than other systems
and are able to provide cross-sectional and longitudinal
data on the prevalence and incidence of diseases in the en-
tire population [6]. Further, in organisations such as the
Spanish National Health Service, in which each patient is
assigned a primary care physician and most interactions
with users occur at the primary care level, the information
provided by primary care health professionals may be par-
ticularly useful [7], especially since the computerization of
medical offices.
The present study focuses on analysing data from rou-
tine administrative healthcare databases. As in many
industrialized countries, the Basque Country has several
information systems that collect data related to the health-
care of chronic conditions. First, there is a hospital dis-
charge data system (HDDS). In addition, since 2005 the
Basque Health Service, Osakidetza, extracts information
from the diagnoses recorded by primary care physicians on
EHRs to use in population-based case-mix systems. These
data are mainly used to identify trends in morbidity seen in
primary care, assess differences between geographical areas
and profile health professionals. As in other places, the
quality of diagnostic reporting by primary care clinicians is
uneven and there is a significant degree of variability be-
tween professionals [12-14]. An alternative method formonitoring health problems is the identification of con-
ditions from associated prescriptions. The information on
medications recorded in the EHRs may be more
complete and several studies have used this approach to
estimate the prevalence of certain chronic diseases [15-
17]. Additionally, every four years a survey on the health
of the population is undertaken in the Basque Country
(“Encuesta de Salud de la CAPV”, ESCAV) [18]; its find-
ings allow us to monitor self-perceived health and the
prevalence of health problems in our community as
reported by the population itself.
Given the variety of data sources and the intrinsic limita-
tions of each of them, the objective of this study was to de-
scribe the prevalence of a range of chronic diseases
observed in patients under the care of the Basque health
system as currently recorded in various types of adminis-
trative databases and to compare these values. To provide
a context for our results from the health information sys-
tems of our region, we also report the prevalence estimated
by the 2007 Basque Health Interview Survey. In addition,
we observed the variations among practitioners, regarding
the prevalence of disease in the populations they served,
according to the different sources of information.
Methods
This was a descriptive, cross-sectional study. The study
population included all patients over 14 years of age
who were assigned to a physician of the Basque Health
Service (Osakidetza) for at least 6 months between 1st
September 2007 and 31st August 2008 (n=1,964,337), re-
gardless of whether they visited any doctor during this
period or if at the end of the study period they main-
tained public insurance coverage or they had been
removed for any reason (death, home moving or admin-
istrative causes).
Setting
Osakidetza is a public healthcare organisation that pro-
vides universal coverage, funded through regional gen-
eral taxation. Primary care clinicians work in teams and
each person is included on the list of one physician (gen-
eral practitioner [GP] if older than 14 years of age or
paediatrician if younger), who acts as the gatekeeper to
other levels of care. In 2008, there were 1,196 GP patient
lists.
Data sources
For this study we obtained permission from the Basque
Health Service, to use the database of the Basque Coun-
try population stratification program (PREST) [19].
PREST employs an opaque identifier to ensure confi-
dentiality of patients and contains information from
hospital discharge data set (HDDS) and Osakidetza primary
care EHRs. The HDDS is a set of administrative and clinical
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on hospitalisation episodes since 1993 and is based on the
discharge abstracts of patients admitted. Diagnoses are
recorded using the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) codes,
and for this study both primary and secondary diagnoses
have been taken into account.
Our EHRs were designed to facilitate the provision of
individualized care to patients during their visit to a clin-
ician. The computerisation of medical offices started in
1990 and all clinicians have had a computer in their
office since 2005. The health problems of patients are
organised by healthcare episodes [20] and the ICD-9-
CM [21] is used as the system for coding diagnoses; this
task is carried out by the primary care physicians them-
selves when they register or modify the diagnosis of an
episode. We considered as primary care diagnoses all
the ICD-9-CM codes of episodes in which any notes
were entered by any GP during the observation period.
The data on prescriptions were extracted from the
specific forms completed in primary care EHRs and their
coding, according to the Anatomical Therapeutic Chem-
ical (ATC) Classification System [22], was performed by
the Subdepartment for Healthcare of Osakidetza.
Identification of patients with chronic diseases
A total of 12 health problems were selected and the
Adjusted Clinical Groups [23] Case-Mix System was
used to identify people with each of these conditions.
This system presents patient morbidity data in a range
of different ways and, for this study, we focused on two
of them:
– Expanded Diagnosis Clusters (EDCs): 267 groupings
generated by the aggregation of ICD-9-CM coded
diagnoses, according to clinical criteria. They were
designed in order to enable the identification of
patients with specific diseases, decreasing the
differences in coding behavior between practitioners.
– Rx-Morbidity Groups (Rx-MGs): 64 groupings from
a classification system based on the drugs prescribed
(ATC coding system). These groups were designed
according to four criteria: primary anatomical-
physiological system, morbidity differentiation,
expected duration, and severity of the health
problem being acted by the medication.
Since the objective was to compare the prevalence of
various chronic diseases as estimated from these differ-
ent data sources, we selected health problems for which
it is easy to establish a relationship between Rx-MGs
and the corresponding EDCs. Under Spanish law, the
drugs used to treat these conditions always require a
doctor's prescription and can not be sold directly topatients as over the counter drugs. For some conditions
there is more than one classification group, so in order
to simplify the analysis data were merged. Thus, for dia-
betes, the four corresponding EDCs were combined, as
were the two Rx-MGs, in order to create a single group
of patients diagnosed with diabetes and another single
group of patients receiving anti-diabetic medication;
similarly, the two EDCs related to the diagnosis of arter-
ial hypertension were grouped together.
The prevalence of the diseases in the general popula-
tion was obtained from the various data sets: hospital
diagnoses, primary care prescriptions and diagnoses sep-
arately and, subsequently, by combining the two sources
of diagnoses (primary care and HDDS) and these with
the prescription data. A patient was considered to have a
medical condition if any of the diagnoses given or the
drugs prescribed in the previous 12 months were
included in the corresponding morbidity groups (EDCs
or Rx-MGs). Since we used combined data on diagnoses
and prescriptions, a patient could have both an EDC and
an Rx-MG that indicate the same medical condition.
Obviously, in such cases the patient was counted only
once in the prevalence estimate.
Statistical analysis
For the subpopulations assigned to each GP, prevalence
rates were calculated based on three combinations of
data: only primary care diagnoses, all the diagnoses (pri-
mary care and hospital) and the combination of prescrip-
tion data with all the diagnoses. In order to compare the
values for each GP, standardized morbidity ratios (SMRs)
were calculated. The SMR is the ratio of the observed
number of patients with a disease to the expected num-
ber obtained by indirectly adjusting for age and sex the
overall prevalence data across Osakidetza. A value above
1.00 (for example, 1.20) indicates that the number of
patients diagnosed with a specific medical condition by a
given doctor is higher than the average across all the GPs
in the Basque Country (in this case, 20% higher); the op-
posite being true for values under 1.00. A detailed de-
scription of this process for EDCs can be found in the
literature [24].
In order to evaluate the dispersion of the data, namely
the spread of the three SMR values for each medical
condition, the variances were calculated and their differ-
ences were assessed using the Brown-Forsythe test for
homogeneity of variances.
Results
Of the population analysed, 51% were women
(n=1,006,793) and 22% (n=422,719) were 65 or older.
Overall, there were 188,051 admissions to hospital and
10,463,390 primary care visits. A total of 70% of
patients (1,381,383) visited their GP at least once
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required one or more admissions. From the HDDS we
retrieved 664,185 diagnoses and from primary care EHRs
18,586,949 diagnoses and 22,518,451 prescriptions.
Table 1 shows the prevalence of the medical conditions
studied in the general population by data source. The esti-
mations obtained from the prescription data were higher
than those arising from the diagnoses recorded in all cases,
except for malignant neoplasm. On the other hand, for mi-
graine higher values were obtained from the survey than
using the combination of prescriptions and diagnoses.
Table 2 reports the analysis of the prevalence of each of
the health problems on the GP patient lists: the variances
of the SMRs based only on primary care diagnoses were
the highest and those based on the combination of diagno-
ses and prescriptions were the lowest in all cases. In five of
the diseases studied, there were no statistically significant
differences in variances between the two sources of diagno-
sis data (primary alone and the combination of primary
care and hospital), though there were differences when
comparing the combination of diagnoses with the combin-
ation of diagnoses and prescriptions.
Figure 1a and 1b show plots of the distribution of the
SMRs for the GPs and illustrate the wider spread of the
values obtained using the primary care diagnoses versus
the combination of all of the diagnoses and prescription
data. Beanplots were used rather than boxplots as, given






n % n % n %
Hypertension 30.342 1.54% 193.449 9.85% 207.685 10.5
Lipid metabolism disorder 12.757 0.65% 140.285 7.14% 149.328 7.60
Depression 3.841 0.20% 25.103 1.28% 28.080 1.43
Asthma 3.557 0.18% 42.953 2.19% 44.710 2.28
Diabetes 13.452 0.68% 81.074 4.13% 84.913 4.32
Osteoporosis 2.134 0.11% 25.361 1.29% 26.917 1.37
Chronic heart failure 5.766 0.29% 6.785 0.35% 10.518 0.54
Hypothyroidism 2.047 0.10% 27.965 1.42% 29.147 1.48
Malignant neoplasm 10.316 0.53% 28.820 1.47% 33.156 1.69
Glaucoma 1.057 0.05% 14.543 0.74% 15.183 0.77
Migraine 326 0.02% 11.234 0.57% 11.463 0.58
Parkinson´s disease 867 0.04% 3.095 0.16% 3.571 0.18
Notes:
Total study population: 1,964,337 (over 14 years of age).
Dx: Diagnoses refers to individuals who have visited their general practitioner or ha
of the listed medical conditions during the 12 months of the study.
Rx: Prescriptions means that in the primary care electronic medical record there is a
month period) from which it is deduced that the patient has one of the listed med
These three sources of information are not exclusive – a single patient may be dete
and prescriptions data, although only is counted once.
The health survey covered all the population, including children.particularly useful for comparing data coming from differ-
ent groups [25].
Discussion
Administrative databases can be a very useful tool for
epidemiological surveillance: they not only enable us to
estimate the incidence and prevalence of medical condi-
tions, but also to identify cohorts of patients with a
given diagnosis and follow their progression over time
including the outcomes of the care they have received
[26]. Nevertheless, that represents a secondary use of
the data, for purposes other than that for which they
were originally recorded, and the validity of the results
obtained should be assessed carefully [6].
While there is no universally accepted gold standard
to establish the exact prevalence of a medical condition
in a given population, other studies have indicated that
the detection of chronic diseases from administrative
databases leads to an underestimate [6,27], especially
when data used cover just one year, as in our case. The
data from hospital discharge abstracts make it possible
to identify chronic patients whose conditions are more
severe or not under adequate control, but used alone
provide limited information concerning other conditions
[28] such as those considered in our study.
In our case, using different data sources we obtained
inconsistent prevalence estimates. Specifically, in 11 of
the 12 diseases studied prescription data indicated arce
d) Rx Dx (combined)
+ Rx
2007 Basque Health Survey
(ESCAV)
n % n % Survey description
7% 321.930 16.39% 347.344 17.68% 11.60% High blood pressure
% 188.704 9.61% 253.458 12.90% 6.50% High Cholesterol
% 120.162 6.12% 127.612 6.50% 3.30% Anxiety-Depression
% 118.361 6.03% 127.208 6.48% 3.80% Asthma
% 82.994 4.23% 102.355 5.21% 3.40% Diabetes
% 68.091 3.47% 74.371 3.79% 2.10% Osteoporosis
% 62.756 3.19% 64.191 3.27%
% 53.240 2.71% 63.553 3.24% 2.20% Thyroid Problems
% 19.040 0.97% 45.970 2.34% 0.8% Cancer
% 39.047 1.99% 41.895 2.13%
% 14.497 0.74% 20.428 1.04% 1.9% Migraine
% 8.214 0.42% 8.883 0.45%
ve been admitted to hospital and have been diagnosed at least once with one
n entry corresponding to the issuing of a prescription (during the same 12-
ical conditions.
cted as having one these medical conditions through hospital, primary care
Table 2 Variance in standardised morbidity ratios between doctor’s lists by data source
Mean Variance Interquartile range Homoscedasticity
PHC Dx vs. All Dx All Dx vs. Dx + Rx
Hypertension PHC Dx 1.02 0.15 0.46
All Dx 1.02 0.11 0.41 0.0009 0.0001
Dx + Rx 1.01 0.04 0.20
Lipid metabolism disorder PHC Dx 1.00 0.26 0.61
All Dx 1.00 0.22 0.57 0.0438 0.0001
Dx + Px 0.99 0.08 0.34
Depression PHC Dx 1.00 0.54 0.91
All Dx 1.00 0.44 0.81 0.0057 0.0001
Dx + Rx 1.00 0.10 0.36
Asthma PHC Dx 1.01 0.31 0.67
All Dx 1.01 0.28 0.66 0.2547 0.0001
Dx + Rx 1.01 0.12 0.42
Diabetes PHC Dx 1.02 0.15 0.49
All Dx 1.02 0.13 0.45 0.0252 0.0001
Dx + Rx 1.01 0.07 0.34
Osteoporosis PHC Dx 1.00 0.38 0.74
All Dx 1.00 0.33 0.69 0.1063 0.0001
Dx + Rx 0.98 0.09 0.35
Chronic heart failure PHC Dx 1.04 0.58 0.90
All Dx 1.03 0.29 0.68 0.0001 0.0001
Dx + Rx 1.02 0.10 0.37
Hypothyroidism PHC Dx 0.99 0.41 0.81
All Dx 1.00 0.39 0.78 0.4667 0.0001
Dx + Rx 1.01 0.17 0.51
Malignant neoplasm PHC Dx 1.00 0.19 0.57
All Dx 1.00 0.12 0.46 0.0001 0.0001
Dx + Rx 1.00 0.07 0.33
Glaucoma PHC Dx 1.02 0.51 0.87
All Dx 1.01 0.46 0.81 0.1693 0.0001
Dx + Rx 0.99 0.13 0.37
Migraine PHC Dx 1.00 0.40 0.74
All Dx 1.00 0.39 0.74 0.5502 0.0001
Dx + Rx 1.00 0.20 0.52
Parkinson´s disease PHC Dx 1.02 0.68 1.03
All Dx 1.02 0.57 0.93 0.0137 0.0001
Dx + Rx 1.01 0.29 0.57
PHC = Primary Health Care; All Dx = PHC diagnoses + Hospital DDS; Dx + Rx = PHC diagnoses + Hospital DDS + PHC prescriptions.
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hospital diagnoses. Further, except in the case of mi-
graine, the combination of prescriptions and both
sources of diagnoses produced higher estimates than
those found in the health survey.
The differences between prevalence estimates for GP
lists were smaller taking into account the combinationof diagnoses and prescriptions, than using only diagnosis
data. Although the distribution of medical conditions be-
tween patient populations under the care of different
doctors is not random [29], the differences found in our
analysis seem too large to be only attributable to dispar-
ities in the morbidity burden of the populations, espe-
cially if we consider diagnoses alone. Indeed, there are
Figure 1 Comparison of the distribution of the Standardized Morbidity Ratio by doctor’s lists in the medical conditions under study,
by data source: primary health care diagnoses (PCH Dx) and the combination of primary care and hospital diagnoses and primary care
prescriptions (Dx + Rx). Horizontal lines correspond to values of percentiles 25 and 75.
Orueta et al. BMC Health Services Research 2012, 12:365 Page 6 of 8
http://www.biomedcentral.com/1472-6963/12/365differences in the quality of the notes entered by physi-
cians; it should be taken into account that in our health
service the computerisation of patient data has been vol-
untary and some doctors still use paper records or pre-
scription forms and EHRs in parallel. It cannot be
proven from our study that the combination of data
sources leads to a more accurate identification of
patients with chronic diseases, but it seems reasonable
to assume that adding pharmacy data does enable us to
compensate for part of the variability attributable to the
practices of doctors (in terms of entering diagnoses). We
presume that flaws in physicians’ records correspond to
lack of sensitivity rather than specificity and, accord-
ingly, the simultaneous utilization of multiple data
sources will notably improve sensitivity without a signifi-
cant decrease of specificity.
In primary care, the completeness of data entry regarding
diagnoses is influenced by a range of factors related to theorganisation of the health service, the patients and the doc-
tors themselves [17,30,31]. It should be taken into account
that, in our case, the primary care data were extracted dir-
ectly from the EHRs in which GPs enter notes to support
the care provided to their patients; many doctors may con-
sider it important to record the diagnosis but not necessary
to enter the corresponding code. Moreover, clinicians use a
wide variety of terms to describe a diagnosis, correspond-
ing to diseases, syndromes, and symptoms, as well as com-
plaints described by patients and other reasons for seeking
medical attention [32], and often these do not conform to
standard terminology. The ICD-9-MC system was origin-
ally developed for the hospital setting and its use in pri-
mary care is not straightforward. This may be particularly
true in our system, since it is physicians themselves who
must code diagnoses and they may consider that they are
being asked to make an unnecessary effort to identify dif-
ferences between terms which, in their opinion, are not
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tives for clinicians and the effort required, some doctors do
not systematically code their diagnoses and, often (as men-
tioned above), leave entries concerning morbidity as free
text notes only or incompletely coded [12-14]. This situ-
ation may be especially common in relation to chronic dis-
eases such as those studied here and, indeed, it has been
reported that doctors enter less accurate data on patients
with multiple conditions and older patients, groups for
which coding may be more challenging [17].
As we have discussed, another option for detecting
health problems is prescription data [34]. Records of
medication prescribed provides a list of medical condi-
tions treated, which in some cases may be more
complete than records of diagnoses; in our case, phar-
macy data may be especially useful to obtain data on
patients who only visit their GP for repeat prescriptions,
given that their condition is stable, and do not require
medical attention from their GP as their pathology is
being managed through specialised outpatient services.
A method based exclusively on prescriptions would not,
however, be able to adequately describe the whole mor-
bidity burden: on the one hand, there are many drugs
which have numerous therapeutic uses and many med-
ical conditions which do not have a specific pharmaco-
logical treatment and, on the other, it could lead to
overestimation of prevalence among patients on the lists
of doctors who tend to prescribe drugs rather than indi-
cate other forms of treatment (e.g., nutritional advice for
those with hyperlipidaemia).
The prevalence estimates we obtained using prescrip-
tion data could seem too high, being bigger than those
derived from survey data. In contrast, in a recent study
carried out in Italy, comparing results from a range of
different data sources, prevalence estimates from surveys
were higher than those from pharmaceuticals prescribed
for 9 out of 12 conditions studied, though the method
for classifying drugs was different to the one we used
[35]. In our case, the coding of the medications was car-
ried out automatically, which minimises errors and
avoids manipulation by clinicians and the classification
of the drugs was performed by the robust, widely-used
ACG Case-Mix System. This system recognizes that
there are few drugs used to treat a single health prob-
lem; medications are assigned to categories, which can
correspond to symptoms, general treatments within an
organ system, and specific ones for a particular disease,
trying to preserve the latter to the situations in which it
has been possible to establish a 1-to-1 relation between
the drug and the pathology. Further, the differences we
found between prevalence estimates based on pharmacy
data and on diagnoses are in line with the findings of an-
other study carried out in a Spanish population [36].
The concordance between self-report of chronic diseasesand administrative databases or registries in EHR has
been studied by other authors, finding a fair-to-
moderate agreement in the prevalences obtained from
these sources [10,37].
Our study has certain limitations. First, although in a
tax-financed insurance system that provides universal
coverage, there are fewer barriers to healthcare access than
in other models of care, such situation is not perfect. Thus,
to the extent that some population subgroups might have
a poorer access to services, their health problems would be
less accurately registered. In this sense, it is not possible to
rule out a certain selection bias, but this would have influ-
enced all of data and it seems unlikely that it produced dis-
similar effects on the values obtained from diagnoses,
prescriptions or both sources. On the other hand, it was
not possible to access the registers of Emergency Depart-
ments or specialist outpatient services; these would have
provided valuable information, in particular, concerning
patients who have the more severe forms of chronic condi-
tions, or in the case of problems which are by their nature
episodic, such as asthma, and others which need specia-
lized medical care but do not require admission (for ex-
ample, chemotherapy for cancer patients). In addition, we
adopted relatively loose criteria, accepting that a patient
presented a given condition even when there was only one
recording of a diagnosis or associated prescription, so some
errors due to mistakes in data entry by physicians could be
overlooked. Further, the particular characteristics of our
health service and the EHRs used make it difficult to ex-
trapolate these results to other systems. Indeed, it is very
difficult to compare our results with those of other studies,
given substantial differences in methodology and, actually,
there is not even a universally accepted definition of a
chronic disease.
Conclusions
We underline the need to be cautious when estimating
the prevalence of medical conditions from data recorded
for other purposes, as there may be remarkable biases in
records. On the other hand, given the growing use of
computers in medical offices, the complementary use of
a range of data sources (in our case, diagnoses on hos-
pital discharge abstracts, and primary care prescriptions
and diagnoses) may be a feasible option to improve the
accuracy of such estimations.
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